电子邮件 | jha***@***.com | 获取Email |
---|
电子邮件 | jha***@***.com | 获取Email |
---|
Dicerna, a wholly owned subsidiary of Novo Nordisk, is focused on driving innovation in RNAi (ribonucleic acid interference) to selectively target and silence genes that cause or contribute to disease. Using our proprietary GalXC™ and GalXC-Plus™ RNAi technologies, we discover and develop innovative RNAi-based therapies with the potential to treat both rare and more prevalent diseases. By silencing disease-causing genes, our GalXC platform has the potential to address conditions that are difficult to treat with other modalities. Initially focused on disease-causing genes in the liver, we have continued to innovate and are exploring new applications of our RNAi technology with GalXC-Plus, which expands on the functionality and application of our flagship liver-targeted GalXC technology to tissues and cell types outside the liver with the potential to treat diseases across multiple therapeutic areas. Our team brings together talented experts across the fields of biology, chemistry, clinical science, medicine and more. With decades of scientific and technical experience focused on RNAi technology, we have the knowledge and experience needed to discover and develop therapies for patients with serious unmet medical needs. Between our own pipeline of core discovery and clinical candidates and those developed through collaborative relationships with some of the world's leading pharmaceutical companies, we have generated more than 20 active discovery, preclinical or clinical proprietary and collaborative programs focused on rare, cardiometabolic, viral, chronic liver and complement-mediated diseases, as well as neurodegenerative diseases and pain.
公司 | Dicerna Pharmaceuticals, Inc. |
---|---|
职位 | Head of Program Initiation |
地点 | United States |
http://www.linkedin.com/in/john-hanrahan-md-mph-fccp-70b63015 | |
部门 | |
头衔 | Head of Program Initiation at Dicerna Pharmaceuticals, Inc. |
Dicerna Pharmaceuticals, Inc. Head of Program Initiation
2020-07-01 -
Senior Medical Director
2019-05-01 - 2020-07-01
Ironwood Pharmaceuticals Senior Medical Director
2015-04-01 - 2019-05-01
Chief Medical Officer
2013-06-01 - 2015-05-01
MD, MPH
2012-01-01 -
John Hanrahan 在 Dicerna Pharmaceuticals, Inc. 担任 Head of Program Initiation at Dicerna Pharmaceuticals, Inc.
John Hanrahan 在 Dicerna Pharmaceuticals, Inc. 的职位是 Head of Program Initiation at Dicerna Pharmaceuticals, Inc.
John Hanrahan 的电子邮件地址是 jha***@***.com
John Hanrahan 的电话号码是 -
John Hanrahan 的公司电话号码是 +161****
John Hanrahan 在 pharmaceuticals 工作。
John Hanrahan 的一些同事包括Amy Mahan、Nicole Lykens、Rachel、John FeinbergKimberly Kuhl、。
John Hanrahan联系方式: 电子邮件地址:jha***@***.com 电话号码:-
John Hanrahan 的个人领英是:http://www.linkedin.com/in/john-hanrahan-md-mph-fccp-70b63015
John Hanrahan 的办公地点:75 Hayden Avenue, Lexington, Massachusetts, USA, 02421
Top-ranked on G2 Crowd
全球B2B企业库 海关贸易数据 展会采购数据
全球B2B企业库
海关贸易数据
展销采购数据
Top-ranked on G2 Crowd